• About John Howley
JOHN HOWLEY, ESQ.
  • About John Howley

Pfizer Settles Protonix Off-Label Marketing Case for $55 Million

12/14/2012

0 Comments

 
Picture
Pfizer Inc. has agreed to pay $55 million plus interest to settle allegations that Wyeth LLC, a Pfizer subsidiary, promoted the prescription drug Protonix for off-label use.

Protonix is a proton pump inhibitor (PPI) that was used by physicians to treat various forms of gastro-esophageal reflux disease (GERD).  The Food and Drug Administration (FDA) approved Protonix for short-term treatment of erosive esophagitis, a condition associated with GERD that can only be diagnosed with an invasive endoscopy.

The government alleged that Wyeth engaged in a “multifaceted” campaign to promote Protonix for all forms of GERD, including symptomatic GERD, which was far more common and could be diagnosed without an endoscopy.  These other uses were not approved by the FDA.

Under the Federal Food Drug and Cosmetic Act, manufacturers must obtain FDA approval for any indication for use for which a manufacturer intends to market a drug.  A prescription drug that is intentionally marketed for unapproved off-label uses is considered “misbranded.”

The government alleged that Wyeth intentionally engaged in the following conduct to promote Protonix for off-label use:
  • training its sales force to promote Protonix for all forms of GERD;
  • promoting Protonix to physicians for unapproved uses;
  • promoting Protonix as the “best PPI for nighttime heartburn,” even though there was no clinical evidence that Protonix was more effective than any other PPI for nighttime heartburn;
  • retaining an outside market research firm to ensure that sales representatives delivered that misleading superiority message;
  • using continuing medical education (CME) programs to promote Protonix for unapproved uses.

Pfizer denied the allegations, and the settlement resolves the case without a finding of guilt or innocence.


While the Pfizer case was brought by the government directly, many off-label promotion cases are brought by whistleblowers.  Under the qui tam provisions of the False Claims Act, whistleblowers are entitled to a reward of up to 30% of the amount of money the government recovers.  In some cases, the rewards in pharmaceutical cases have reached millions of dollars.

If you have information that a pharmaceutical company is promoting its drugs for off-label uses, then you should consult with an experienced False Claims Act attorney immediately.  To schedule a free and confidential consultation by telephone or in person, call my office today at (917) 652-6504 or click here to communicate with me via email.

John Howley, Esq.



The information you obtain at this site is not, nor is it intended to be, legal advice. You should consult an attorney for advice regarding your individual situation.  I invite you to contact our law offices and welcome your calls, letters and electronic mail.  Contacting us does not create an attorney-client relationship.  Please do not send any confidential information to us until such time as an attorney-client relationship has been established.  I practice law and offer legal services only in jurisdictions where I am properly authorized to do so.  I do not seek to represent anyone in any jurisdiction where this web site does not comply with applicable laws and bar rules.
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Picture
    John Howley, Esq.
    350 Fifth Avenue 59FL
    New York, NY 10118
    (212) 601-2728

    Employment Law

    Healthcare Fraud

    Whistleblower Rewards
Get an Experienced Advocate On Your Side​
John Howley is available to consult with potential clients by telephone, video-conference, or in person.  All consultations are by appointment.  To schedule a consultation, call our offices today at (212) 601-2728.
Click to Call


​Follow John Howley, Esq.

Follow John Howley, Esq. on social media for the latest legal news and updates.



​John Howley, Esq. | 1345 6th Ave 2nd floor | New York, NY 10105 | (212) 601-2728
​
​Copyright (c) 2012-2023 by John Howley, Esq.  This web site is for educational purposes only,  It does not provide legal advice, nor does it solicit clients seeking legal advice or representation.  To the extent it may be considered attorney advertising, readers are cautioned that prior results do not guarantee a similar outcome.
  • About John Howley